Advanced Filters
noise

Human Papilloma Virus (HPV) Clinical Trials

A listing of Human Papilloma Virus (HPV) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 199 clinical trials
A Alice Richman

The Role of Dentists in Human Papillomavirus Vaccination

This project involves the research into understanding the functioning of co-located/partnering dental practices and federally qualified health centers/community health clinics in North Carolina and how dental health providers may play a role in facilitating HPV vaccination uptake for under-vaccinated populations in these co-located/partnering sites.

18 - 100 years of age Both Phase N/A
G Gregor Jemec, DMSc, MD

The Organ Transplant Recipient HPV and Skin Cancer Study

Solid organ transplant recipients (OTRs) receive lifelong immunosuppressive therapy, which puts them at increased risk of cutaneous and mucosal cancers. In particular, OTRs have increased risk of skin cancer and cancers caused by human papillomavirus (HPV), including cervical cancer and oropharyngeal cancer. There is currently limited knowledge on risk factors …

18 - 100 years of age Both Phase N/A
R Radwa Aly

The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples

Cervical cancer is primarily caused by Human Papillomaviruses (HPV). Testing for HPV in cervical samples is now an option for cervical cancer screening. HPV can also be tested from self-collected samples which may help to improve access to screening, since it does not require a doctor visit. However, many women …

30 - 69 years of age Female Phase N/A
Y Yebin Yu

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

To access the immune persistence of Chinese women aged 9-45 years after receiving quadrivalent HPV vaccine with the immunization schedule of 0, 2 and 6 months.

9 - 45 years of age Female Phase N/A

Longitudinal HPV Pap in CIN and VAIN

This study will construct a longitudinal risk model of VaIN according to the HPVs distribution of cervix and vaginal for those had CIN2+. The study will include three arms to complete the follow-up data for the previous cohort constructed, and prospectively recruit new subjects with the appropriate inclusion/excluding criteria in …

20 - 100 years of age Female Phase N/A
Y Yogesh Verma, MD

Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.

18 - 22 years of age Female Phase N/A

SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)

The goal is to assess the feasibility and acceptability of integrating into existing health systems, provision of HPV screening and treatment of pre-cancerous cervical cancer lesions with ablative treatments in Burkina Faso, Côte d'Ivoire, Guatemala, and the Philippines. Study findings will inform implementation of cervical cancer prevention and treatment services …

25 - 49 years of age Both Phase N/A

Cervical Cancer Screening With NGS-HPV Technology Based on Menstrual Blood

Our study is conducted to recruit cervical cancer screening patients to evaluate the application value of using high-throughput sequencing technology to detect HPV in menstrual blood for cervical cancer screening.

20 - 55 years of age Female Phase N/A
X XIAO Juan, Master

The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

Cervical cancer is one of the most common cancer in women, making it the fourth largest cause of female cancer mortality worldwide. High-risk HPV types (hrHPV) continuous infection is the main cause of the premalignant and malignant lesions of the cervix. The most effective primary prevention of cervical cancer is …

16 - 40 years of age Female Phase N/A
A Alaa CHEIKHELARD, MD

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease

The main objective of the study is to determine the vaccination coverage rate for human papillomavirus in adolescents aged 11 to 20 with chronic disease and treated at the Necker-Enfants Malades Hospital, compared to a population witnessed adolescent girls aged 11 to 20 years without chronic disease.

11 - 20 years of age Female Phase N/A

Rewrite in simple language using AI